摘要
目的:为了观察马蔺子素配合放射治疗食管癌的增敏疗效及其毒副反应。方法:从1996年6月至1997年6月采用马蔺子素配合放疗治疗食管癌患者36例(增敏组)与单纯放疗组36例(对照组),进行临床观察。结果:肿瘤消退率在增敏组为72.2%(26/36)对照组为52.8%(19/36),两组间差展显著(P〈0.05),肿瘤消失时照射总剂量,在增敏组为56.2Cy,对照组为64.2Gy,增敏比为1.13,临床症状改善,进食梗阻改善率,增敏组为75%(27/36),对照组为54%(20/36),胸背疼痛消失两组无显差异,外周白细胞低于4×10^9L者,增敏组为22%(8/36),和59%(21/36),对照组为61%(22/36)和42%(15/36)。
Objective:To study the radiosensitive effect and the toxicity of Irisquinones (Iq 7611) combining radiotherapy in the treatment of esophageal carcinoma. Methods:36 patients of esophageal carcinoma treated with combination of Iq and RT,and 36 patients with radiotherapy alone were admitted from June 1996to June 1997.Results: In the combination group, the response rate was 72.2% (26/36), and the response rate of RT alone was 52.8(19/36) (P< 0.05). The total radiation dosage of tumor disappearance was 56.2Gy in radiosensitive group and it was 64.2Gy in the control. Enhancement ratio were 1.13. In the group, the improvement of colinical symptom and disappearance rate of obstruction was 75 % (27/36), in the control it was 54% (20/36). The disappearance of checkache and backache was no significant difference in the two groups. Leucocyte < 4 X 109 /L was 22 % (8 /36), the 1 - year, 2 ?year survival rates were 75%(27/36) and 58%(21/36)in the combinationgroup,and it were 42%(15/36), 61%(22/36) and 42%(15/ 36) in the control. Conclnsion:The study shows that combination treatment of Iq and RT can improve the response rate of tumor and short ?term survival with significant radiosensitive effect and without special toxicity. It is a worthy radiosensitizer.
出处
《临床肿瘤学杂志》
CAS
2000年第4期272-274,共3页
Chinese Clinical Oncology
关键词
马蔺子素
放射增敏
食管癌
疗效
放射疗法
Irisquinones (Iq7611) Radiosensitive effect Esophageal carcinoma